id,title,publish_time,close_time,resolution,question_id,t,x
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:25:21.419002771,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 04:37:11.002724409,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:25:21.419002771,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 04:37:11.002724409,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 04:52:38.560933828,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 04:52:38.560933828,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 05:49:27.185922384,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 05:51:48.110347986,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 05:49:27.185922384,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 05:51:48.110347986,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 18:26:51.460421801,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 18:32:24.634518623,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 09:37:31.189688206,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 18:26:51.460421801,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 18:32:24.634518623,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 09:37:31.189688206,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 18:26:51.460421801,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 18:32:24.634518623,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 09:37:31.189688206,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:15:59.414982080,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:27:43.427058935,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:28:13.103603601,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:28:17.590077162,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:15:59.414982080,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:27:43.427058935,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:28:13.103603601,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:28:17.590077162,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:52:12.156713009,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:16:54.724009991,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:52:12.156713009,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:16:54.724009991,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 21:20:05.495103836,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 21:20:05.495103836,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:45:02.377231598,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:45:58.446099281,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:46:02.115670681,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:45:02.377231598,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:45:58.446099281,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:46:02.115670681,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:55:34.038579464,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:55:34.038579464,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 05:55:34.038579464,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 00:39:32.247190237,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 15:23:24.814419270,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 00:39:32.247190237,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 15:23:24.814419270,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:16:54.372325420,0.63
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:16:54.372325420,0.63
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:20:49.653388739,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:20:49.653388739,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:55:10.208746910,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:55:10.208746910,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:02:14.350981951,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:02:14.350981951,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:02:14.350981951,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 04:34:40.197860003,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 04:34:42.899500847,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 04:34:44.777426958,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 04:34:40.197860003,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 04:34:42.899500847,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 04:34:44.777426958,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 12:35:20.147760391,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 12:36:17.302717209,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 12:35:20.147760391,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 12:36:17.302717209,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:25.003619671,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:28.247492790,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:25.003619671,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:28.247492790,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:25.003619671,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:28.247492790,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:25.003619671,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:28.247492790,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:25.003619671,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 02:41:28.247492790,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:05:10.528423309,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:05:10.528423309,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 14:36:26.226803303,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 14:36:26.226803303,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 14:36:26.226803303,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 14:36:26.226803303,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 14:36:26.226803303,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:38:55.614538908,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 10:39:45.785126209,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 04:34:08.872439384,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 04:34:08.872439384,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 04:34:08.872439384,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 16:34:38.683795691,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 16:34:38.683795691,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 16:34:38.683795691,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 16:34:38.683795691,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 16:34:38.683795691,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 09:59:29.407504082,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 09:59:35.032711506,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 09:59:29.407504082,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 09:59:35.032711506,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:56:21.544699430,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:56:21.544699430,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:56:21.544699430,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:56:21.544699430,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:56:21.544699430,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 11:28:01.926777363,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 11:28:01.926777363,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 14:11:40.734250784,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 01:34:01.715082645,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 14:11:40.734250784,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 01:34:01.715082645,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 14:11:40.734250784,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 01:34:01.715082645,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 14:11:40.734250784,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 01:34:01.715082645,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 14:11:40.734250784,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 01:34:01.715082645,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 12:32:20.997348309,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 12:32:20.997348309,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 12:51:57.209911823,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 12:51:57.209911823,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:25:48.794286966,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:25:48.794286966,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 02:49:22.296365023,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 02:49:22.296365023,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 21:11:44.301629066,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 21:11:44.301629066,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 10:31:24.350160360,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 10:31:24.350160360,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 10:31:24.350160360,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 10:31:24.350160360,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 10:31:24.350160360,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 01:05:23.250429391,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 16:40:54.797145605,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:47:45.285166502,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 01:05:23.250429391,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 16:40:54.797145605,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:47:45.285166502,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 01:05:23.250429391,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 16:40:54.797145605,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:47:45.285166502,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 01:05:23.250429391,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 16:40:54.797145605,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:47:45.285166502,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 01:05:23.250429391,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 16:40:54.797145605,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:47:45.285166502,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 01:05:23.250429391,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 16:40:54.797145605,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:47:45.285166502,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:43.238998413,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:43.238998413,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:43.238998413,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:43.238998413,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:31:45.685992718,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:33:33.623224735,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:30:41.930754662,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:31:45.685992718,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:33:33.623224735,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:30:41.930754662,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:31:45.685992718,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:33:33.623224735,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:30:41.930754662,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:31:45.685992718,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:33:33.623224735,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:30:41.930754662,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:31:45.685992718,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:33:33.623224735,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:30:41.930754662,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 18:21:34.687974930,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 11:16:53.833294630,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 11:16:53.833294630,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:06:26.637970924,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 06:44:18.266184330,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:06:26.637970924,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 06:44:18.266184330,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 02:59:24.458312750,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 02:59:24.458312750,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:11:40.151557684,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:11:40.151557684,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:22:12.617372513,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:03:30.336537838,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 03:22:12.617372513,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:03:30.336537838,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:01:18.890979052,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:01:18.890979052,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:18:26.666512728,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:18:30.994035006,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:18:26.666512728,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:18:30.994035006,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:18:26.666512728,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:18:30.994035006,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:18:26.666512728,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:18:30.994035006,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:18:26.666512728,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:18:30.994035006,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:21:21.566130638,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:21:21.566130638,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:21:21.566130638,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 10:27:14.868829727,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 16:31:58.685173512,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 10:27:14.868829727,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 16:31:58.685173512,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 23:10:17.201429844,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 23:10:17.201429844,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 23:10:17.201429844,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:41:59.211456299,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:42:18.228893757,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:41:59.211456299,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:42:18.228893757,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:41:59.211456299,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:42:18.228893757,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:41:59.211456299,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:42:18.228893757,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:41:59.211456299,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 17:42:18.228893757,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 11:35:18.034079552,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 11:35:18.034079552,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 16:18:52.391235828,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 16:18:52.391235828,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 17:02:07.238646984,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 17:02:07.238646984,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 17:02:07.238646984,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 17:04:05.366976738,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 17:04:05.366976738,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 21:07:47.675238371,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 21:07:49.936938524,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 21:07:47.675238371,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 21:07:49.936938524,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:52:54.565604687,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:52:54.565604687,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 22:59:58.083580017,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 22:59:58.083580017,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 22:59:58.083580017,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 22:59:58.083580017,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 23:07:54.164936781,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:06:34.447193861,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 23:07:54.164936781,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:06:34.447193861,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 23:07:54.164936781,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:06:34.447193861,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 23:07:54.164936781,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:06:34.447193861,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 23:07:54.164936781,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:06:34.447193861,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 23:07:54.164936781,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:06:34.447193861,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 11:08:45.680995703,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 11:08:45.680995703,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 11:08:45.680995703,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:40:15.727962255,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:22:44.229667425,0.83
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:28:14.797052622,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:18.359307528,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:26.150882721,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:40:15.727962255,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:22:44.229667425,0.83
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:28:14.797052622,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:18.359307528,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:26.150882721,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:40:15.727962255,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:22:44.229667425,0.83
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:28:14.797052622,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:18.359307528,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:26.150882721,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:40:15.727962255,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:22:44.229667425,0.83
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:28:14.797052622,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:18.359307528,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:26.150882721,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:40:15.727962255,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:22:44.229667425,0.83
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:28:14.797052622,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:18.359307528,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:26.150882721,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:40:15.727962255,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:22:44.229667425,0.83
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 22:28:14.797052622,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:18.359307528,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 03:00:26.150882721,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:50:05.031140566,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:50:05.031140566,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 00:32:12.205282450,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:37:18.473733902,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:04:53.515219926,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:05:13.709063053,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 00:32:12.205282450,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:37:18.473733902,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:04:53.515219926,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:05:13.709063053,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 00:32:12.205282450,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:37:18.473733902,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:04:53.515219926,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:05:13.709063053,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 00:32:12.205282450,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:37:18.473733902,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:04:53.515219926,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:05:13.709063053,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 00:32:12.205282450,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:37:18.473733902,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:04:53.515219926,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:05:13.709063053,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 00:32:12.205282450,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 20:37:18.473733902,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:04:53.515219926,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:05:13.709063053,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 11:53:49.633156061,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 11:53:49.633156061,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:30:07.008872747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:30:10.894942760,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:22:45.381027699,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:30:07.008872747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:30:10.894942760,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:22:45.381027699,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:31:33.181992769,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:31:33.181992769,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:54:24.274919510,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:54:24.274919510,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:54:24.274919510,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 18:04:03.875158072,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 18:04:03.875158072,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 03:26:52.036293983,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:11:02.338236570,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:44:19.245344877,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 00:23:02.505831241,0.64
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 20:36:53.722730160,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 00:23:02.505831241,0.64
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 20:36:53.722730160,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 18:57:58.379784346,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 18:57:58.379784346,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 15:05:17.373731136,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 15:05:17.373731136,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 00:30:29.307850122,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:27.648560286,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 18:39:38.029178858,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:21:35.717179537,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:21:35.717179537,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:21:35.717179537,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:21:35.717179537,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:21:35.717179537,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 13:15:56.667497873,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 13:15:56.667497873,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 13:15:56.667497873,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 19:02:55.636707544,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 21:36:00.853448391,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 19:57:10.869291067,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 19:02:55.636707544,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 21:36:00.853448391,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 19:57:10.869291067,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:43:06.387201786,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 19:55:23.110826492,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:43:06.387201786,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 19:55:23.110826492,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:43:06.387201786,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 19:55:23.110826492,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:43:06.387201786,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 19:55:23.110826492,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:43:06.387201786,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 19:55:23.110826492,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:43:06.387201786,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 19:55:23.110826492,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:20:15.669664145,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 11:53:12.261220455,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:20:15.669664145,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 11:53:12.261220455,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 14:20:15.669664145,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 11:53:12.261220455,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:23:42.756522179,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:23:42.756522179,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 17:58:07.149632454,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:47:10.009056807,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 17:58:07.149632454,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:47:10.009056807,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 19:29:18.048574924,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 19:29:18.048574924,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 19:29:18.048574924,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 02:55:19.926146030,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 02:55:19.926146030,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 21:56:16.769876957,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:35:40.633324385,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:06:27.549306631,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 16:59:01.054316998,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:06:27.549306631,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 16:59:01.054316998,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:16:47.248106956,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:51:41.493561745,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:16:47.248106956,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:51:41.493561745,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 22:05:52.454381227,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 22:05:52.454381227,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:22:49.208159208,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:22:49.208159208,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 06:07:11.028649807,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 06:07:11.028649807,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 06:07:11.028649807,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 06:07:11.028649807,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:47:19.812024832,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:47:19.812024832,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:47:19.812024832,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:47:19.812024832,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:47:19.812024832,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 19:47:19.812024832,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:45:25.526331185,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 00:45:25.526331185,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:56:00.159365177,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 05:56:00.159365177,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 23:26:52.865848064,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 23:30:24.660396814,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 23:26:52.865848064,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 23:30:24.660396814,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 06:14:46.228012800,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 04:48:10.583436966,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 06:14:46.228012800,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 04:48:10.583436966,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:22:24.057002306,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:40:12.990435123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:22:24.057002306,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:40:12.990435123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:22:24.057002306,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:40:12.990435123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:22:24.057002306,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:40:12.990435123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:22:24.057002306,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:40:12.990435123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:22:24.057002306,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:40:12.990435123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 07:02:00.210935116,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 07:02:21.055382013,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 07:02:00.210935116,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 07:02:21.055382013,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 14:57:34.158591986,0.66
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 14:57:34.158591986,0.66
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 14:57:34.158591986,0.66
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 23:54:21.129019737,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 23:54:21.129019737,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:31:10.183228493,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:32:30.087504148,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:31:10.183228493,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:32:30.087504148,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:31:10.183228493,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:32:30.087504148,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:31:10.183228493,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:32:30.087504148,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:31:10.183228493,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:32:30.087504148,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:31:10.183228493,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:32:30.087504148,0.87
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:01:25.760871887,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:18:50.366495371,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:21:13.713972330,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 16:59:22.378476381,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 18:32:01.809777975,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:01:25.760871887,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:18:50.366495371,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:21:13.713972330,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 16:59:22.378476381,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 18:32:01.809777975,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 02:24:53.902186871,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 02:24:53.902186871,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 02:24:53.902186871,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 02:24:53.902186871,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 07:43:37.744552374,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 07:43:37.744552374,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 07:43:37.744552374,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 07:43:37.744552374,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 07:43:37.744552374,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 14:55:20.078326941,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 13:31:47.967270374,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:14:06.662130356,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:41:00.378772020,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:01:45.926667452,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 15:09:20.526175976,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 14:55:20.078326941,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 13:31:47.967270374,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 12:14:06.662130356,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:41:00.378772020,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:01:45.926667452,0.79
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 15:09:20.526175976,0.8
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:28:58.574148178,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:28:58.574148178,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 18:31:45.972767830,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:51:02.077060938,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 18:31:45.972767830,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:51:02.077060938,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-10 18:31:45.972767830,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:51:02.077060938,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:40:10.365941525,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:01:00.602123022,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:52:29.517451286,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:40:10.365941525,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:01:00.602123022,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:52:29.517451286,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:40:10.365941525,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:01:00.602123022,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:52:29.517451286,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 09:40:10.365941525,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:01:00.602123022,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:52:29.517451286,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 18:54:39.642261982,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 18:54:39.642261982,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 10:15:00.601574898,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:21.386950493,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:35.252785205,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:44:54.789438009,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:45:10.339899540,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 10:15:00.601574898,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:21.386950493,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:35.252785205,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:44:54.789438009,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:45:10.339899540,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 10:15:00.601574898,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:21.386950493,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:35.252785205,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:44:54.789438009,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:45:10.339899540,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 10:15:00.601574898,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:21.386950493,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:35.252785205,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:44:54.789438009,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:45:10.339899540,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 10:15:00.601574898,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:21.386950493,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 18:28:35.252785205,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:44:54.789438009,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:45:10.339899540,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:03:54.911154747,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:03:54.911154747,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:03:54.911154747,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:03:54.911154747,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 01:03:54.911154747,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:36:04.345558167,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 11:46:40.411474228,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:37:40.454014778,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 22:36:04.345558167,0.76
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 11:46:40.411474228,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:37:40.454014778,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 23:58:56.210209846,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 11:13:09.891170263,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 23:58:56.210209846,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 11:13:09.891170263,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 23:58:56.210209846,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 11:13:09.891170263,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 23:58:56.210209846,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 11:13:09.891170263,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 23:58:56.210209846,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 11:13:09.891170263,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 23:58:56.210209846,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 11:13:09.891170263,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:57:33.306710958,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:57:36.955129623,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:57:33.306710958,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:57:36.955129623,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:57:33.306710958,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:57:36.955129623,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:35:24.722113132,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:35:24.722113132,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:24:54.358997107,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:25:05.741804838,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:25:08.141419172,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:24:54.358997107,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:25:05.741804838,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:25:08.141419172,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:24:54.358997107,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:25:05.741804838,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:25:08.141419172,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:24:54.358997107,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:25:05.741804838,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:25:08.141419172,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:24:54.358997107,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-08 13:25:05.741804838,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 07:25:08.141419172,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:16:26.483493567,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:35:25.975435019,0.82
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 21:22:11.964247465,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 06:30:02.090771437,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:04:48.478777170,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 19:09:47.303032637,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:19:32.847040176,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:51:48.455524445,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:20:37.146292210,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 23:59:52.793796539,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:00:01.574555635,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:19.017983675,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:42:39.884809494,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 15:59:56.430299044,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 19:06:58.321268559,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:16:26.483493567,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:35:25.975435019,0.82
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 21:22:11.964247465,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 06:30:02.090771437,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:04:48.478777170,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 19:09:47.303032637,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:19:32.847040176,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:51:48.455524445,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:20:37.146292210,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 23:59:52.793796539,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:00:01.574555635,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:19.017983675,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:42:39.884809494,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 15:59:56.430299044,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 19:06:58.321268559,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:16:26.483493567,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:35:25.975435019,0.82
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 21:22:11.964247465,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 06:30:02.090771437,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:04:48.478777170,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 19:09:47.303032637,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:19:32.847040176,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:51:48.455524445,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:20:37.146292210,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 23:59:52.793796539,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:00:01.574555635,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:19.017983675,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:42:39.884809494,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 15:59:56.430299044,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 19:06:58.321268559,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:16:26.483493567,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:35:25.975435019,0.82
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 21:22:11.964247465,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 06:30:02.090771437,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:04:48.478777170,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 19:09:47.303032637,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:19:32.847040176,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:51:48.455524445,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:20:37.146292210,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 23:59:52.793796539,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:00:01.574555635,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:19.017983675,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:42:39.884809494,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 15:59:56.430299044,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 19:06:58.321268559,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:16:26.483493567,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:35:25.975435019,0.82
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 21:22:11.964247465,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 06:30:02.090771437,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:04:48.478777170,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 19:09:47.303032637,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:19:32.847040176,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:51:48.455524445,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:20:37.146292210,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 23:59:52.793796539,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:00:01.574555635,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:19.017983675,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:42:39.884809494,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 15:59:56.430299044,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 19:06:58.321268559,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 18:16:26.483493567,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 20:35:25.975435019,0.82
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 21:22:11.964247465,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 06:30:02.090771437,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 16:04:48.478777170,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 19:09:47.303032637,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 19:19:32.847040176,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:51:48.455524445,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 16:20:37.146292210,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 23:59:52.793796539,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 00:00:01.574555635,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 04:50:19.017983675,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 15:42:39.884809494,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 15:59:56.430299044,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 19:06:58.321268559,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 05:29:09.649835110,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 05:29:09.649835110,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 10:06:07.501961707,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 19:53:02.846043587,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:21:22.817659140,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 08:26:48.689524412,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:55:11.971863747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:15:09.574237108,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 08:19:47.713847399,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 13:11:02.852516413,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:36:07.635678053,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 08:02:08.545337915,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 09:41:09.992432117,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 08:07:25.934285641,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 20:55:07.259705782,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:03:04.814618826,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:02:00.060631752,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:09:28.246731520,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:15:40.051375389,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 10:06:07.501961707,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 19:53:02.846043587,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:21:22.817659140,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 08:26:48.689524412,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:55:11.971863747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:15:09.574237108,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 08:19:47.713847399,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 13:11:02.852516413,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:36:07.635678053,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 08:02:08.545337915,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 09:41:09.992432117,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 08:07:25.934285641,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 20:55:07.259705782,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:03:04.814618826,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:02:00.060631752,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:09:28.246731520,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:15:40.051375389,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 10:06:07.501961707,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 19:53:02.846043587,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:21:22.817659140,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 08:26:48.689524412,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:55:11.971863747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:15:09.574237108,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 08:19:47.713847399,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 13:11:02.852516413,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:36:07.635678053,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 08:02:08.545337915,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 09:41:09.992432117,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 08:07:25.934285641,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 20:55:07.259705782,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:03:04.814618826,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:02:00.060631752,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:09:28.246731520,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:15:40.051375389,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 10:06:07.501961707,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 19:53:02.846043587,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:21:22.817659140,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 08:26:48.689524412,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:55:11.971863747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:15:09.574237108,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 08:19:47.713847399,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 13:11:02.852516413,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:36:07.635678053,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 08:02:08.545337915,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 09:41:09.992432117,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 08:07:25.934285641,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 20:55:07.259705782,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:03:04.814618826,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:02:00.060631752,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:09:28.246731520,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:15:40.051375389,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 10:06:07.501961707,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 19:53:02.846043587,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:21:22.817659140,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 08:26:48.689524412,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:55:11.971863747,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 21:15:09.574237108,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 08:19:47.713847399,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 13:11:02.852516413,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 19:36:07.635678053,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 08:02:08.545337915,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 09:41:09.992432117,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 08:07:25.934285641,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 20:55:07.259705782,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 20:03:04.814618826,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:02:00.060631752,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 20:09:28.246731520,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:15:40.051375389,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 23:33:49.334522486,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 04:43:18.423121929,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:26:32.773581743,0.78
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 23:33:49.334522486,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 04:43:18.423121929,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:26:32.773581743,0.78
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 18:46:29.126934290,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:02:27.515643596,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:51:18.014018059,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 14:41:27.633255243,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 18:46:29.126934290,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 18:02:27.515643596,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 21:51:18.014018059,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 14:41:27.633255243,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 17:17:25.849527359,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 17:17:25.849527359,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 03:31:43.435961246,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:37:32.982476473,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:37:45.856773138,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 03:31:43.435961246,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:37:32.982476473,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 15:37:45.856773138,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:11:15.192421913,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 04:58:59.230123043,0.8675510847654432
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 06:16:12.102508783,0.9068084229376323
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 04:16:36.632053137,0.8819413369165185
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:12:58.625801563,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:02.074198723,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:13.437299490,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:31:31.799404383,0.931072955315698
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 05:11:24.052704811,0.9098086690259255
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 06:09:14.497956514,0.956740830833346
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:11:15.192421913,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 04:58:59.230123043,0.8675510847654432
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 06:16:12.102508783,0.9068084229376323
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 04:16:36.632053137,0.8819413369165185
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:12:58.625801563,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:02.074198723,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:13.437299490,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:31:31.799404383,0.931072955315698
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 05:11:24.052704811,0.9098086690259255
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 06:09:14.497956514,0.956740830833346
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:11:15.192421913,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 04:58:59.230123043,0.8675510847654432
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 06:16:12.102508783,0.9068084229376323
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 04:16:36.632053137,0.8819413369165185
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:12:58.625801563,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:02.074198723,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:13.437299490,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:31:31.799404383,0.931072955315698
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 05:11:24.052704811,0.9098086690259255
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 06:09:14.497956514,0.956740830833346
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:11:15.192421913,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 04:58:59.230123043,0.8675510847654432
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 06:16:12.102508783,0.9068084229376323
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 04:16:36.632053137,0.8819413369165185
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:12:58.625801563,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:02.074198723,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:13.437299490,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:31:31.799404383,0.931072955315698
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 05:11:24.052704811,0.9098086690259255
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 06:09:14.497956514,0.956740830833346
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:11:15.192421913,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 04:58:59.230123043,0.8675510847654432
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 06:16:12.102508783,0.9068084229376323
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 04:16:36.632053137,0.8819413369165185
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:12:58.625801563,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:02.074198723,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:13.437299490,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:31:31.799404383,0.931072955315698
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 05:11:24.052704811,0.9098086690259255
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 06:09:14.497956514,0.956740830833346
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:11:15.192421913,0.7
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 04:58:59.230123043,0.8675510847654432
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-07 06:16:12.102508783,0.9068084229376323
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 04:16:36.632053137,0.8819413369165185
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:12:58.625801563,0.89
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:02.074198723,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 20:13:13.437299490,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 04:31:31.799404383,0.931072955315698
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 05:11:24.052704811,0.9098086690259255
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 06:09:14.497956514,0.956740830833346
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:57:08.445248842,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:08:54.270495176,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:43:01.060887814,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:57:08.445248842,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:08:54.270495176,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:43:01.060887814,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:57:08.445248842,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:08:54.270495176,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:43:01.060887814,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:57:08.445248842,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:08:54.270495176,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:43:01.060887814,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 20:57:08.445248842,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 20:08:54.270495176,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 08:43:01.060887814,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 15:38:17.335268974,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 15:38:17.335268974,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:27:54.804475546,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:30:35.018232107,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:05:39.951934576,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 18:16:46.711526871,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:31:07.412514925,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:35:08.451908588,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:35:47.172176123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 13:44:10.153928041,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:27:54.804475546,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:30:35.018232107,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:05:39.951934576,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 18:16:46.711526871,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:31:07.412514925,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:35:08.451908588,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:35:47.172176123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 13:44:10.153928041,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:27:54.804475546,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 17:30:35.018232107,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-05 19:05:39.951934576,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 18:16:46.711526871,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:31:07.412514925,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:35:08.451908588,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 15:35:47.172176123,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 13:44:10.153928041,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 17:59:26.879428864,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:53:52.654532194,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:57:14.838299990,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 17:59:26.879428864,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:53:52.654532194,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:57:14.838299990,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 02:42:26.719251633,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 19:14:41.103314877,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 20:26:43.042571545,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:58:25.640328407,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:00:48.765090466,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 02:42:26.719251633,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 19:14:41.103314877,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 20:26:43.042571545,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 22:58:25.640328407,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:00:48.765090466,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:01:21.712254047,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:01:21.712254047,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:54:38.497930288,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 23:03:05.366131783,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 21:04:53.680731058,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 12:53:04.255487204,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 12:53:18.083540678,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:43:48.099889517,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:45:03.853984594,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:46:16.806386709,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:46:48.809751511,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 15:02:55.129311084,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:43:27.568259239,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:23:37.223696947,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:54:38.497930288,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 23:03:05.366131783,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 21:04:53.680731058,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 12:53:04.255487204,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 12:53:18.083540678,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:43:48.099889517,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:45:03.853984594,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:46:16.806386709,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:46:48.809751511,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 15:02:55.129311084,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:43:27.568259239,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:23:37.223696947,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 22:54:38.497930288,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 23:03:05.366131783,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 21:04:53.680731058,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 12:53:04.255487204,0.91
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 12:53:18.083540678,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:43:48.099889517,0.71
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:45:03.853984594,0.68
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:46:16.806386709,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 01:46:48.809751511,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 15:02:55.129311084,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 14:43:27.568259239,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:23:37.223696947,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 02:02:15.206707239,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:51:32.592493296,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 02:02:15.206707239,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:51:32.592493296,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 02:02:15.206707239,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:51:32.592493296,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 02:02:15.206707239,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:51:32.592493296,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-11 02:02:15.206707239,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 23:51:32.592493296,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 00:30:36.100548506,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 00:30:36.100548506,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 17:16:23.993372917,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 17:16:56.974374294,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 00:45:17.908333778,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 17:16:23.993372917,0.72
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 17:16:56.974374294,0.75
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 00:45:17.908333778,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:14:29.722094536,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 22:13:46.551250458,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 18:35:26.603176117,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 07:02:05.456677675,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 03:15:50.546804428,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 22:23:46.794889450,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 23:49:35.686107159,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:32:42.017514706,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:32:55.423903704,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:33:01.648762703,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:34:20.386898994,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:34:30.012658358,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:34:42.751699686,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:35:13.075578451,0.84
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 07:32:05.193820715,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 04:53:36.180381298,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 04:53:38.352334261,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 16:58:28.800338507,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 16:58:31.971332550,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-19 05:50:00.178974628,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-19 05:50:01.952965260,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 06:52:55.194902182,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 06:52:57.763225555,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:05:20.361247063,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:05:31.081038952,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:06:00.894453049,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:06:08.298998356,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:31:54.871318340,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:31:57.027875662,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:32:26.382184505,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:32:31.848958254,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 02:50:12.526240349,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 02:50:18.051337719,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 05:22:19.338770390,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 05:22:21.465480566,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 05:40:24.877263546,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 05:40:26.820111513,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 19:02:31.694837809,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 19:02:34.982462883,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 02:57:20.998784542,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 02:57:23.805898666,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 07:33:06.552130699,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 07:33:13.363370180,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-06 20:14:29.722094536,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-09 22:13:46.551250458,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-12 18:35:26.603176117,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-13 07:02:05.456677675,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 03:15:50.546804428,0.9
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-14 22:23:46.794889450,0.95
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-15 23:49:35.686107159,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:32:42.017514706,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:32:55.423903704,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:33:01.648762703,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:34:20.386898994,0.92
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:34:30.012658358,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:34:42.751699686,0.73
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-16 06:35:13.075578451,0.84
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-17 07:32:05.193820715,0.86
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 04:53:36.180381298,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 04:53:38.352334261,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 16:58:28.800338507,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-18 16:58:31.971332550,0.97
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-19 05:50:00.178974628,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-19 05:50:01.952965260,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 06:52:55.194902182,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-20 06:52:57.763225555,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:05:20.361247063,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:05:31.081038952,0.88
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:06:00.894453049,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-21 23:06:08.298998356,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:31:54.871318340,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:31:57.027875662,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:32:26.382184505,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-22 14:32:31.848958254,0.85
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 02:50:12.526240349,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 02:50:18.051337719,0.94
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 05:22:19.338770390,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-23 05:22:21.465480566,0.98
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 05:40:24.877263546,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 05:40:26.820111513,0.93
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 19:02:31.694837809,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-24 19:02:34.982462883,0.96
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 02:57:20.998784542,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 02:57:23.805898666,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 07:33:06.552130699,0.99
6492,Will the single-dose Johnson & Johnson SARS-CoV-2 vaccine be issued an emergency use authorization by the US FDA within a week after the 26 February VRBPAC meeting?,2021-02-05 18:00:00+01:00,2021-02-25 23:00:00+01:00,1.0,6492,2021-02-25 07:33:13.363370180,0.99
